Bristol-Myers Squibb

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments, pharmaceuticals and nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.
Company Growth (employees)
New York, US
Size (employees)
25,000 (est)
Bristol-Myers Squibb was founded in 1887 and is headquartered in New York, US

Key People at Bristol-Myers Squibb

Giovanni Caforio

Giovanni Caforio

Chief Executive Officer
Charles Bancroft

Charles Bancroft

Executive Vice President, CFO
Francis Cuss

Francis Cuss

Executive Vice President and Chief Scientific Officer
Lamberto Andreotti

Lamberto Andreotti

Chairman, Board of Directors

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in New York, Jacksonville, Atlanta, Birmingham and in 169 other locations
New York, US (HQ)
345 Park Avenue

Bristol-Myers Squibb Metrics

Bristol-Myers Squibb Financial Metrics

Revenue (2016)

$19.4 b

Revenue growth (2015-16), %


Gross profit

$14.5 b

Gross profit margin (2016), %


Net income (2016)

$4.5 b

Market capitalization (21-Mar-2017)

$93.7 b

Closing share price (21-Mar-2017)


Cash (31-Dec-2016)

$4.2 b
Bristol-Myers Squibb's current market capitalization is $93.7 b.
Bristol-Myers Squibb's revenue was reported to be $19.4 b in FY, 2016 which is a 17.3% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$16.4 b$15.9 b$16.6 b$19.4 b

Revenue growth, %


Cost of goods sold

$4.6 b$3.9 b$3.9 b$4.9 b

Gross profit

$11.8 b$11.9 b$12.7 b$14.5 b

Gross profit Margin, %


Operating expense total

$13.5 b$13.5 b$14.5 b$13.5 b

Pre tax profit

$2.9 b$2.4 b$2.1 b$5.9 b

Income tax expense

$311 m$352 m$446 m$1.4 b

Net Income

$2.6 b$2 b$1.6 b$4.5 b
FY, 2013FY, 2014FY, 2015FY, 2016


$3.6 b$5.6 b$2.4 b$4.2 b


$1.5 b$1.6 b$1.2 b$1.2 b

Current Assets

$18.9 b$14.6 b$10.4 b$13.7 b


$7.1 b$7 b$6.9 b$6.9 b

Total Assets

$38.6 b$33.7 b$31.7 b$33.7 b

Accounts Payable

$2.6 b$2.5 b$1.6 b$1.7 b

Dividends Payable

$634 m$645 m$655 m

Total Debt

$8.3 b$7.8 b$6.7 b$6.7 b

Current Liabilities

$12.4 b$8.5 b$8 b$8.8 b

Retained Earnings

$33 b$32.5 b$31.6 b$33.5 b

Total Equity

$15.2 b$15 b$14.4 b$16.3 b

Debt to Equity Ratio

0.5 x0.5 x0.5 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.2 x

Financial Leverage

2.5 x2.3 x2.2 x2.1 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$2.6 b$2 b$1.6 b$4.5 b


($45 m)($254 m)$97 m($152 m)

Accounts Payable

$412 m($44 m)($919 m)$104 m

Cash From Operating Activities

$3.5 b$3.1 b$1.8 b$2.9 b

Capital Expenditures

($820 m)($1.2 b)

Cash From Investing Activities

($572 m)$1.2 b($1.6 b)$1.5 b

Long-term Borrowings

($597 m)($676 m)($2 b)($15 m)

Cash From Financing Activities

($1.1 b)($2.4 b)($3.4 b)($2.4 b)

Free Cash Flow

$2.7 b$4.1 b

Bristol-Myers Squibb Operating Metrics

Y, 2015Y, 2016

Ongoing Phase III Programs


Projects in R&D Pipeline


Bristol-Myers Squibb Market Value History

Bristol-Myers Squibb Median Salaries

Source: 359 public H-1B filings from Bristol-Myers Squibb

Bristol-Myers Squibb Online Presence

Bristol-Myers Squibb Company Life

You may also be interested in